VALN - Valneva wins WHO nod for COVID-19 vaccine

• The World Health Organization (WHO) on Thursday recommended VLA2001, the inactivated whole-virus COVID-19 vaccine, developed by French vaccine maker Valneva ( NASDAQ: VALN ) for the prevention of coronavirus disease.
• The decision follows the WHO’s Strategic Advisory Group of Experts (SAGE) meeting on immunization conducted last week.
• WHO also gave the go-ahead to use a second booster shot of the vaccine for certain individuals at risk of developing the severe disease.
• The U.S. biotech Dynavax Technologies ( DVAX ) has partnered with Valneva ( VALN ) to deliver the CpG 1018 adjuvant used in the vaccine.
• In June, European regulators authorized the vaccine for primary vaccination against COVID-19 in those aged 18 – 50. The EU approval covered 28 EU member states as well as Iceland, Liechtenstein, and Norway.

For further details see: